Showing results (131-140 of 280) with videos related to
Sort By:
Pageof 28
Digestive Diseases and Sciences|July 23, 2003
In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrinElizabeth A Griffiths, Linda C Duffy, Floyd L Schanbacher, et al.Blood|June 15, 2007
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemiasJudith E Karp, Rebecca M Ricklis, Kumudha Balakrishnan, et al.Haematologica|April 16, 2013
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trialSteven D Gore, Pierre Fenaux, Valeria Santini, et al.Clinical Lymphoma, Myeloma & Leukemia|December 16, 2014
Real-life experience of a brief arsenic trioxide-based consolidation chemotherapy in the management of acute promyelocytic leukemia: favorable outcomes with limited anthracycline exposure and shorter consolidation therapyMindy Leech, Lawrence Morris, Moishe Stewart, et al.Transfusion|May 3, 2020
A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an optionMarc Zumberg, Jed Gorlin, Elizabeth A Griffiths, et al.Leukemia Research Reports|May 3, 2017
Dexrazoxane for cardioprotection in older adults with acute myeloid leukemiaPankit Vachhani, Sarah Shin, Jeffrey Baron, et al.American Journal of Hematology|March 27, 2015
Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years oldNeha Gupta, Austin Miller, Shipra Gandhi, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2010
NCCN Task Force: Transfusion and iron overload in patients with myelodysplastic syndromesPeter L Greenberg, Cynthia K Rigsby, Richard M Stone, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk featuresJudith E Karp, B Douglas Smith, Ivana Gojo, et al.JNCI Cancer Spectrum|July 31, 2019
Association Between Ownership of Imaging Equipment and Appropriateness of Staging Positron-Emission Tomography in Non-Hodgkin LymphomaScott F Huntington, Weiwei Zhu, Jessica R Hoag, et al.Pageof 28